Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.19 - $10.31 $1,438 - $2,062
200 New
200 $1,000
Q1 2024

May 15, 2024

SELL
$9.86 - $13.74 $491,028 - $684,252
-49,800 Reduced 99.6%
200 $2,000
Q4 2023

Feb 14, 2024

BUY
$7.1 - $10.89 $352,870 - $541,233
49,700 Added 16566.67%
50,000 $544,000
Q3 2023

Nov 14, 2023

SELL
$6.95 - $9.89 $45,870 - $65,274
-6,600 Reduced 95.65%
300 $2,000
Q2 2023

Aug 14, 2023

BUY
$8.59 - $14.56 $59,271 - $100,464
6,900 New
6,900 $66,000
Q4 2022

Feb 14, 2023

SELL
$8.71 - $14.28 $104,520 - $171,360
-12,000 Reduced 84.51%
2,200 $30,000
Q3 2022

Nov 14, 2022

BUY
$7.19 - $9.91 $24,949 - $34,387
3,470 Added 32.34%
14,200 $129,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $304M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.